10:27 AM EDT, 10/30/2024 (MT Newswires) -- (Updates with more details in the fifth paragraph and the latest stock move in the last paragraph.)

AbbVie ( ABBV ) reported Q3 adjusted earnings Wednesday of $3.00 per diluted share, up from $2.95 a year earlier.

Analysts surveyed by Capital IQ expected $2.92.

Net revenue for the quarter ended Sept. 30 was $14.46 billion, up from $13.93 billion a year earlier. Analysts surveyed by Capital IQ expected $14.28 billion.

The biopharmaceutical company raised its fiscal 2024 adjusted EPS guidance to a range of $10.90 to $10.94, from $10.67 to $10.87 previously. Analysts surveyed by Capital IQ expect $10.85.

AbbVie ( ABBV ) raised its quarterly dividend to $1.64 per share from $1.55 per share, payable Feb. 14 to shareholders of record as of Jan. 15, the company said.

The company's shares were up 1.8% in recent Wednesday trading.

Price: 192.90, Change: +3.45, Percent Change: +1.82